Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling
Silva, Marcondes A. B., Bruder-Nascimento, Thiago, Cau, Stefany B. A., Lopes, Rheure A. M., Mestriner, Fabiola L. A. C., Fais, Rafael S., Touyz, Rhian M., Tostes, Rita C.Volume:
6
Language:
english
Journal:
Frontiers in Physiology
DOI:
10.3389/fphys.2015.00269
Date:
October, 2015
File:
PDF, 3.19 MB
english, 2015